1. Home
  2. ADIL vs BBGI Comparison

ADIL vs BBGI Comparison

Compare ADIL & BBGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADIL
  • BBGI
  • Stock Information
  • Founded
  • ADIL 2010
  • BBGI 1961
  • Country
  • ADIL United States
  • BBGI United States
  • Employees
  • ADIL N/A
  • BBGI N/A
  • Industry
  • ADIL Biotechnology: Pharmaceutical Preparations
  • BBGI Broadcasting
  • Sector
  • ADIL Health Care
  • BBGI Consumer Discretionary
  • Exchange
  • ADIL Nasdaq
  • BBGI Nasdaq
  • Market Cap
  • ADIL 7.6M
  • BBGI 7.6M
  • IPO Year
  • ADIL 2018
  • BBGI 2000
  • Fundamental
  • Price
  • ADIL $0.38
  • BBGI $4.30
  • Analyst Decision
  • ADIL Strong Buy
  • BBGI
  • Analyst Count
  • ADIL 1
  • BBGI 0
  • Target Price
  • ADIL $8.00
  • BBGI N/A
  • AVG Volume (30 Days)
  • ADIL 4.2M
  • BBGI 8.6K
  • Earning Date
  • ADIL 08-19-2025
  • BBGI 08-12-2025
  • Dividend Yield
  • ADIL N/A
  • BBGI N/A
  • EPS Growth
  • ADIL N/A
  • BBGI N/A
  • EPS
  • ADIL N/A
  • BBGI N/A
  • Revenue
  • ADIL N/A
  • BBGI $234,823,730.00
  • Revenue This Year
  • ADIL N/A
  • BBGI $5.02
  • Revenue Next Year
  • ADIL N/A
  • BBGI N/A
  • P/E Ratio
  • ADIL N/A
  • BBGI N/A
  • Revenue Growth
  • ADIL N/A
  • BBGI N/A
  • 52 Week Low
  • ADIL $0.22
  • BBGI $3.67
  • 52 Week High
  • ADIL $1.30
  • BBGI $14.95
  • Technical
  • Relative Strength Index (RSI)
  • ADIL 43.03
  • BBGI 51.89
  • Support Level
  • ADIL $0.39
  • BBGI $4.03
  • Resistance Level
  • ADIL $0.46
  • BBGI $4.31
  • Average True Range (ATR)
  • ADIL 0.08
  • BBGI 0.19
  • MACD
  • ADIL -0.01
  • BBGI 0.02
  • Stochastic Oscillator
  • ADIL 7.29
  • BBGI 50.00

About ADIL Adial Pharmaceuticals Inc

Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.

About BBGI Beasley Broadcast Group Inc.

Beasley Broadcast Group Inc is a multi-platform media company, whose primary business is operating radio stations throughout the United States. The company offers local and national advertisers integrated marketing solutions across audio, digital and event platforms. It owns and operates stations in the following markets: Atlanta, GA, Augusta, GA, Boston, MA, Charlotte, NC, Detroit, MI, Fayetteville, NC, Fort Myers-Naples, FL, Las Vegas, NV, Middlesex, NJ, Monmouth, NJ, Morristown, NJ, Philadelphia, PA, Tampa-Saint Petersburg, FL, and Wilmington, DE. The company operates in two segments Audio and Digital.

Share on Social Networks: